The review started in 2019, and then COVID happened. It paused the review, I assume, and provided a ton of flexibility, and now we're going back. Is this where we're at now? Are we through the review process?
What would be the holdup, then, of approving a country like the U.K., for example? Is that more on the trade side of things, or is Health Canada the hurdle here? What is slowing things down?